Search - tctmd.com

Displaying 301 - 320 of 367

Sort: Relevancy | Date

News Daily News

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

December 04, 2014

News Daily News

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

December 04, 2014

News Daily News

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

L.A. McKeown

November 06, 2014

News Daily News

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

L.A. McKeown

November 06, 2014

News Daily News

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

L.A. McKeown

November 06, 2014

Presentation TCT 2014

Case Presentation Conclusion: How and Why Did We Treat? What Were the Outcomes?

Presenter: Ajay J. Kirtane, David Taggart, Molly Szerlip

September 15, 2014

Presentation TCT 2014

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Presenter: Ajay J. Kirtane, David Taggart, David J. Maron

September 15, 2014

Presentation TCT 2014

Forget Hybrid Do the Whole Thing Robotically!

Presenter: Ajay J. Kirtane, David Taggart, Michael DECEASED J. Davidson

September 15, 2014

Presentation TCT 2014

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Presenter: Ajay J. Kirtane, David Taggart

September 15, 2014

Presentation TCT 2014

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

Presenter: Ajay J. Kirtane, David Taggart, Molly Szerlip

September 15, 2014

Presentation TCT 2014

How Did I Treat This Case?

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Rui Campante Teles

September 15, 2014

Presentation TCT 2014

How Would I Treat This Case?

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Pedro Canas da Silva

September 15, 2014

Presentation TCT 2014

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

Presenter: Andrea Abizaid, Marco A. Costa, Helio R Figueira, Helder Horta Pereira, Mathew Williams, Rui Campante Teles

September 15, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

August 20, 2014

News Daily News

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

L.A. McKeown

August 07, 2014

News Daily News

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

L.A. McKeown

August 07, 2014

News Daily News

Initial Kidney Protection of Off-Pump CABG May Not Last

Caitlin E. Cox

June 04, 2014

News Conference News ACC 2014

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

L.A. McKeown

March 30, 2014

Presentation PCI Outcomes 2014

Case Study 3: PCI vs CABG For Left Main CAD

Presenter: Davide Capodanno

March 28, 2014

Advertisement

La Revascularización Híbrida para la Enfermedad Multivaso parece Viable y Segura

Hybrid Revascularization for Multivessel Disease Appears Feasible, Safe

El Debut de los SLF No logró Alterar el Beneficio sobre la Supervivencia de CABG frente a PCI en la Enfermedad Multivaso

DES的问世没有改变CABG在多支血管治疗方面相对于PCI的优越性

Debut of DES Failed to Alter Survival Benefit of CABG vs PCI in Multivessel Disease

Case Presentation Conclusion: How and Why Did We Treat? What Were the Outcomes?

Wheres the Data for Any of This? Medical Therapy First Is Most Appropriate!

Forget Hybrid Do the Whole Thing Robotically!

PCI Is Just as Good as CABG for This Patient but Lower Risk!

Case Presentation: An Asymptomatic Patient with a Positive Stress Test and Focal Three Vessel Disease

How Did I Treat This Case?

How Would I Treat This Case?

Case #1: A Patient with LV Dysfunction, Homograft Failure, and Progressive Coronary Artery Disease After Bypass Surgery and Mitral Repair

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

SYNTAX al cabo de 5 Años: CABG es Más Rentable que la PCI

La Revascularización Híbrida Sigue Sin estar Disponible el Hospitales de EE.UU. Aunque están Probados sus Perfiles de Seguridad y Eficacia

Hybrid Revascularization Still Not Widely Available in US Hospitals Even With Proven Efficacy, Safety

Initial Kidney Protection of Off-Pump CABG May Not Last

No Impact on Safety Seen at Hospitals Performing PCI with No Surgical Backup

Case Study 3: PCI vs CABG For Left Main CAD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content